| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.33B | 42.10B | 40.82B | 38.34B | 42.80B | 39.36B |
| Gross Profit | 10.93B | 11.31B | 10.81B | 10.08B | 11.63B | 11.44B |
| EBITDA | 2.99B | 3.25B | 2.91B | 2.46B | 3.59B | 4.01B |
| Net Income | 871.00M | 852.00M | 868.00M | -576.00M | 1.39B | 2.04B |
Balance Sheet | ||||||
| Total Assets | 30.75B | 34.30B | 32.98B | 29.66B | 30.49B | 28.83B |
| Cash, Cash Equivalents and Short-Term Investments | 5.30B | 6.64B | 6.50B | 6.03B | 5.21B | 4.82B |
| Total Debt | 2.75B | 3.08B | 3.29B | 3.72B | 2.82B | 3.63B |
| Total Liabilities | 10.04B | 11.22B | 10.94B | 10.91B | 11.44B | 12.53B |
| Stockholders Equity | 20.68B | 23.08B | 22.01B | 18.73B | 19.03B | 16.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 801.00M | 1.25B | 410.00M | 1.42B | 1.94B |
| Operating Cash Flow | 0.00 | 1.86B | 2.27B | 1.28B | 2.56B | 2.94B |
| Investing Cash Flow | 0.00 | -1.28B | -2.42B | -680.00M | -1.55B | -1.10B |
| Financing Cash Flow | 0.00 | -696.00M | 181.00M | -2.00M | -756.34M | -1.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥277.98B | 8.85 | ― | 2.33% | 20.23% | 56.48% | |
80 Outperform | ¥334.98B | 19.71 | ― | 1.17% | 29.22% | 29.50% | |
78 Outperform | ¥101.26B | 9.96 | ― | 3.85% | 19.61% | 25.91% | |
76 Outperform | ¥22.26B | 14.08 | ― | 3.31% | 0.67% | 14.92% | |
74 Outperform | ¥305.94B | 11.92 | 7.86% | 2.55% | 5.68% | 41.20% | |
67 Neutral | ¥12.82B | 15.19 | ― | 3.84% | 3.13% | -7.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |